Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21,965 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry.
Kawabata H, Tohyama K, Matsuda A, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Zaike Y, Usuki K, Chiba S, Ishikawa T, Arima N, Nogawa M, Ohta A, Miyazaki Y, Mitani K, Ozawa K, Arai S, Kurokawa M, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes. Kawabata H, et al. Among authors: suzuki t. Int J Hematol. 2017 Sep;106(3):375-384. doi: 10.1007/s12185-017-2250-0. Epub 2017 May 11. Int J Hematol. 2017. PMID: 28497239
Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan.
Sugimoto M, Ito S, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Kawasaki Y, Ashizawa M, Yamamoto C, Fujiwara S, Okazuka K, Hatano K, Sato K, Oh I, Ohmine K, Suzuki T, Muroi K, Kako S, Kanda Y. Sugimoto M, et al. Among authors: suzuki t. Ann Hematol. 2016 Sep;95(9):1513-9. doi: 10.1007/s00277-016-2740-9. Epub 2016 Jul 1. Ann Hematol. 2016. PMID: 27365141
Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.
Kawabata H, Usuki K, Shindo-Ueda M, Kanda J, Tohyama K, Matsuda A, Araseki K, Hata T, Suzuki T, Kayano H, Shimbo K, Chiba S, Ishikawa T, Arima N, Nohgawa M, Miyazaki Y, Kurokawa M, Arai S, Mitani K, Takaori-Kondo A; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes. Kawabata H, et al. Among authors: suzuki t. Int J Hematol. 2019 Nov;110(5):533-542. doi: 10.1007/s12185-019-02710-1. Epub 2019 Jul 29. Int J Hematol. 2019. PMID: 31359362
Pharmacokinetics of alemtuzumab after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52-positive malignancies.
Oshima K, Kanda Y, Nakahara F, Shoda E, Suzuki T, Imai Y, Watanabe T, Asai T, Izutsu K, Ogawa S, Motokura T, Chiba S, Kurokawa M. Oshima K, et al. Among authors: suzuki t. Am J Hematol. 2006 Nov;81(11):875-9. doi: 10.1002/ajh.20694. Am J Hematol. 2006. PMID: 16862551 Free article.
[Reference guide for adult chronic neutropenia].
Yokoyama Y, Takami A, Mori Y, Sato S, Suzuki T, Gosho M, Obara N, Miyazaki Y, Akashi K, Chiba S; 日本医療研究開発機構・難治性疾患実用化研究事業「成人慢性好中球減少症の診療ガイドライン作成に向けた予後追跡調査」研究班. Yokoyama Y, et al. Among authors: suzuki t. Rinsho Ketsueki. 2018;59(7):845-857. doi: 10.11406/rinketsu.59.845. Rinsho Ketsueki. 2018. PMID: 30078793 Japanese.
Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.
Miyazaki Y, Kiguchi T, Sato S, Usuki K, Ishiyama K, Ito Y, Suzuki T, Taguchi J, Chiba S, Dobashi N, Tomita A, Harada H, Handa H, Horiike S, Maeda T, Matsuda M, Ichikawa M, Hata T, Honda S, Iyama S, Suzushima H, Moriuchi Y, Kurokawa T, Yokota K, Ohtake S, Yamauchi T, Matsumura I, Kiyoi H, Naoe T; Japan Adult Leukemia Study Group. Miyazaki Y, et al. Among authors: suzuki t. Int J Hematol. 2022 Aug;116(2):228-238. doi: 10.1007/s12185-022-03347-3. Epub 2022 May 4. Int J Hematol. 2022. PMID: 35508695 Clinical Trial.
21,965 results
You have reached the last available page of results. Please see the User Guide for more information.